TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Pro Medicus Limited ( (AU:PME) ) has shared an announcement.
Pro Medicus Limited has announced an update regarding its ongoing buy-back program, with a total of 4,000 ordinary fully paid securities bought back on the previous day, adding to a cumulative total of 35,001 securities repurchased. This buy-back initiative is part of the company’s strategy to optimize its capital structure and potentially enhance shareholder value, reflecting a proactive approach to managing its financial resources.
The most recent analyst rating on (AU:PME) stock is a Buy with a A$350.00 price target. To see the full list of analyst forecasts on Pro Medicus Limited stock, see the AU:PME Stock Forecast page.
More about Pro Medicus Limited
Pro Medicus Limited operates in the healthcare technology industry, providing advanced imaging solutions and IT services primarily for the medical sector. The company focuses on delivering innovative software solutions that enhance the efficiency and effectiveness of medical imaging and healthcare services.
YTD Price Performance: -0.25%
Average Trading Volume: 174,067
Technical Sentiment Signal: Buy
Current Market Cap: A$26.02B
Learn more about PME stock on TipRanks’ Stock Analysis page.